Fundamentals of Cancer PreventionDavid Alberts, Lisa M. Hess Springer Science & Business Media, 2005 M04 20 - 397 páginas An authoritative work that provides a detailed review of the current status of practice and research in cancer prevention and control – an essential reference guide and tool for primary care physicians, the research community and students. Written as a collaborative work by the faculty of the nationally-renowned Cancer Prevention and Control Program at the Arizona Cancer Center, this book harnesses the expertise of researchers, investigators and clinicians in cancer prevention and control, to provide insights into this field for the benefit of nonspecialists. |
Contenido
Introduction to Cancer Prevention | 1 |
Assessing Human and Economic Benefits of Cancer Prevention | 11 |
The Role of Diet Physical Activity and Body Composition in Cancer Prevention | 25 |
Hereditary Risk for Cancer | 61 |
Human Categories and Health The Power of the Concept of Ethnicity | 85 |
Complementary and Alternative Approaches to Cancer Prevention | 105 |
The Drug Development Process | 131 |
Developing Topical Prodrugs for Skin Cancer Prevention | 139 |
Colorectal Cancer Prevention | 203 |
Lung Cancer Prevention | 223 |
Breast Cancer Prevention | 255 |
Prostate Cancer Prevention | 277 |
Cervical and Endometrial Cancer Prevention | 315 |
Ovarian Cancer Prevention | 349 |
Cancer Survivorship | 363 |
| 393 | |
Otras ediciones - Ver todas
Términos y frases comunes
acid adenomas androgen apoptosis assessment associated Aziz behaviors biomarkers biopsy bone BRCA1 BRCA2 breast cancer breast cancer risk cancer patients cancer prevention Cancer Res cancer survivors cancer syndromes carcinogenesis carcinoma cell lines cellular cervical cancer chemopreventive agents chemotherapy Clin clinical trials colon colonoscopy colorectal cancer CRAS cultural decreased demonstrated detection diagnosed diet dietary disease DNA damage drug endometrial cancer Epidemiol estrogen ethnicity evaluation exposure function gene genetic testing growth hereditary cancer HNPCC hormone human identified immune increased risk individuals inhibition inhibitors intervention intraepithelial neoplasia kinase lesions lung cancer malignant melanoma molecular mortality mutations Natl Cancer Inst niacin NMSC Oncol outcomes ovarian cancer oxidative pathways phase physical activity placebo population potential primary prostate cancer protein rates receptor reduce risk factors role screening selenium skin cancer smoking specific tamoxifen target therapy tion tissue treatment tumor tumor suppressor genes vitamin women